AYTU BIOPHARMA, INC (AYTU) › Total LiabilitiesAYTU BIOPHARMA, INC (AYTU) — Total LiabilitiesAnnual figures by fiscal year, from SEC filings.2014: $6.65M2015: $2.57M2016: $14.26M2017: $11.00M2018: $7.64M2019: $27.63M2020: $58.28M2021: $128.10M2022: $93.31M2023: $97.11M$97.11M2014Total Liabilities (USD)2023Fiscal YearTotal LiabilitiesChange YoY2023$97.11M+4.1%2022$93.31M-27.2%2021$128.10M+119.8%2020$58.28M+110.9%2019$27.63M+261.9%2018$7.64M-30.6%2017$11.00M-22.9%2016$14.26M+455.0%2015$2.57M-61.4%2014$6.65M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share